Staff Profile

Dr Julia Whitehall is a Research Associate in Health Economics at Newcastle University. Her research focuses on the evaluation of healthcare technologies and the generation of high‑quality evidence to inform decision‑making in health policy and clinical practice.

Julia holds a PhD in Colorectal Cancer and Mitochondrial Biology, completed within the Wellcome Centre for Mitochondrial Research at Newcastle University. Following her doctorate, she conducted postdoctoral research in the same field, developing a strong foundation in fundamental biological science and its application to clinical research. She subsequently worked in consultancy within Market Access and Strategy, where she developed expertise in evidence synthesis methodologies and the strategic use of health data. Julia has also worked at the NIHR Innovation Observatory, contributing to horizon scanning and evidence synthesis for stakeholders including the Department of Health and Social Care and NICE.

Currently, as a member of the Newcastle Technology Appraisal Review Group, she contributes advanced statistical and methodological expertise to clinical and cost‑effectiveness assessments within NICE’s Health Technology Evaluation programme.

• Articles

  • Whitehall J, Jayachandran L, Moradi N, Thomson K, Still M, Wallace SA, Ogunyemi A, Sagoo GS, Norman G, Rice S. Accounting for Oral Corticosteroids Tapering and Reduction in Adverse Effect Burden in Health Economic Evaluations: External Assessment Group Perspective. PharmacoEconomics 2026, Epub ahead of print.
  • Yu X, Arden C, Berlinguer-Palmini R, Chen C, Bradshaw C, Smith AL, Whitehall J, White M, Anderson S, Kattner N, Shaw J, Turnbull D, Greaves LC, Walker M. Mitochondrial complex I subunit deficiency promotes pancreatic α-cell proliferation. Molecular Metabolism 2022, 60, 101489.
  • Stamp C, Whitehall JC, Smith ALM, Houghton D, Bradshaw C, Stoll EA, Blain AP, Turnbull DM, Greaves LC. Age-associated mitochondrial complex I deficiency is linked to increased stem cell proliferation rates in the mouse colon. Aging Cell 2021, 20(3), e13321.
  • Smith ALM, Whitehall JC, Bradshaw C, Gay D, Robertson F, Blain AP, Hudson G, Pyle A, Houghton D, Hunt M, Sampson JN, Stamp C, Mallett G, Amarnath S, Leslie J, Oakley F, Wilson L, Baker A, Russell OM, Johnson R, Richardson CA, Gupta B, McCallum I, McDonald SAC, Kelly S, Mathers JC, Heer R, Taylor RW, Perkins ND, Turnbull DM, Sansom OJ, Greaves LC. Age-associated mitochondrial DNA mutations cause metabolic remodeling that contributes to accelerated intestinal tumorigenesis. Nature Cancer 2020, 1, 976-989.
  • Paish H, Reed L, Brown H, Bryan M, Govaere O, Leslie J, Barksby B, GarciaMacia M, Watson A, Xu X, Zaki M, Greaves L, Whitehall J, French J, White S, Manas D, Robinson S, Spoletini G, Griffiths C, Mann DA, Borthwick LA, Drinnan M, Mann J, Oakley F. A bioreactor technology for modelling fibrosis in human and rodent precision-cut liver slices. Hepatology 2019, 70(4), 1377-1391.

• Book Chapter

  • Whitehall JC, Smith ALM, Greaves LC. Mitochondrial DNA Mutations and Ageing. In: Biochemistry and Cell Biology of Ageing: Part III Biomedical Science. Cham: Springer, 2023, pp.77-98.

• Reviews

  • Smith ALM, Whitehall JC, Greaves LC. Mitochondrial DNA mutations in ageing and cancer. Molecular Oncology 2022, 16(18), 3276-3294.
  • Whitehall JC, Greaves LC. Aberrant mitochondrial function in ageing and cancer. Biogerontology 2020, 21(4), 445-459.